Only one study reported no chromothripsis in 16 patients with myeloid malignancy (8 patients with AML, 1 with MDS, and 7 with MPN); however, the karyotype and TP53 mutation status of the patients in that study were not reported [10]. Here, TP53 is linked to myelodysplastic syndrome.